Publications by authors named "Jason A Dubovsky"

Claim this Profile
P
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.
Anita Kumar, Santosha Vardhana, Alison J Moskowitz, Pierluigi Porcu, Ahmet Dogan, Jason A Dubovsky

Blood Adv· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
Sean W Harshman, Alessandro Canella, Paul D Ciarlariello, Kitty Agarwal, Owen E Branson, Jason A Dubovsky

J Proteomics· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panniculitis in Patients Undergoing Treatment With the Bruton Tyrosine Kinase Inhibitor Ibrutinib for Lymphoid Leukemias.
Stephanie K Fabbro, Sabrina M Smith, Jason A Dubovsky, Alejandro A Gru, Jeffrey A Jones

JAMA Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.
Ta-Ming Liu, Jennifer A Woyach, Yiming Zhong, Arletta Lozanski, Gerard Lozanski, Jason A Dubovsky

Blood· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib enhances IL-17 response by modulating the function of bone marrow derived dendritic cells.
Gayathri Natarajan, Cesar Terrazas, Steve Oghumu, Sanjay Varikuti, Jason A Dubovsky

Oncoimmunology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.
Yiming Zhong, Shuai Dong, Ethan Strattan, Li Ren, Jonathan P Butchar, Jason A Dubovsky

J Biol Chem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells.
Shuai Dong, Daphne Guinn, Jason A Dubovsky, Yiming Zhong, Amy Lehman

Blood· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.
Jason A Dubovsky, Ryan Flynn, Jing Du, Bonnie K Harrington, Yiming Zhong

J Clin Invest· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The B-cell receptor pathway: a critical component of healthy and malignant immune biology.
Yiming Zhong, John C Byrd, Jason A Dubovsky

Semin Hematol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.
Ryan Flynn, Jing Du, Rachelle G Veenstra, Dawn K Reichenbach, Angela Panoskaltsis-Mortari, Jason A Dubovsky

Blood· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases.
Yiming Zhong, Amy J Johnson, John C Byrd, Jason A Dubovsky

Postdoc J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL).
Jennifer A Woyach, Engin Bojnik, Amy S Ruppert, Matthew R Stefanovski, Virginia M Goettl, Jason A Dubovsky

Blood· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing.
Jason A Dubovsky, Danielle L Chappell, Bonnie K Harrington, Kitty Agrawal, Leslie A Andritsos

Blood· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Jason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, Jennifer A Woyach, Samantha Jaglowski

Blood· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments.
Laura E Johnson, Jordan T Becker, Jason A Dubovsky, Brian M Olson, Douglas G McNeel

Chin Clin Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidine.
Jason A Dubovsky, John J Powers, Yang Gao, Luis F Mariusso, Eduardo M Sotomayor

Leuk Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
John J Powers, Jason A Dubovsky, P K Epling-Burnette, Lynn Moscinski, Ling Zhang

Leuk Lymphoma· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers.
Jason A Dubovsky, Daniel Wang, John J Powers, Emmanuel Berchmans, Matthew A Smith

Leuk Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circumventing immune tolerance through epigenetic modification.
Jason A Dubovsky, Alejandro Villagra, John J Powers, Hong-Wei Wang, Javier Pinilla-Ibarz

Curr Pharm Des· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
Jason A Dubovsky, Douglas G McNeel, John J Powers, John Gordon, Eduardo M Sotomayor

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biological basis for immunotherapy in patients with chronic myelogenous leukemia.
Javier Pinilla-Ibarz, Bijal Shah, Jason A Dubovsky

Cancer Control· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.
Jason A Dubovsky, Douglas G McNeel

Prostate· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis.
Jason A Dubovsky, Mark R Albertini, Douglas G McNeel

J Immunother· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immune responses to testis antigens in sera from patients with prostate cancer.
Luke H Hoeppner, Jason A Dubovsky, Edward J Dunphy, Douglas G McNeel

Cancer Immun· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis